# CVS HEALTH CORPORATION (CVS) FY2023 Annual P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2023-01-01 to 2023-12-31
- Filing: FY2023 10-K, filed 2024-02-07, accession number 0000064803-24-000007
- Page: https://plicit.ai/financials/cvs/fy2023-annual-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2023-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2023-01-01 through 2023-12-31. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 357,776,000,000 US dollars
- **Total operating costs**: 344,033,000,000 US dollars
- **Operating income**: 13,743,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 2,570,000,000 US dollars
- **Income before income tax provision**: 11,173,000,000 US dollars
- **Income tax provision**: 2,805,000,000 US dollars
- **Net income**: 8,368,000,000 US dollars
- **Net investment income**: 1,153,000,000 US dollars
- **Premiums**: 99,192,000,000 US dollars
- **Products**: 245,138,000,000 US dollars
- **Services**: 12,293,000,000 US dollars
- **Cost of products sold**: 217,098,000,000 US dollars
- **Health care costs**: 86,247,000,000 US dollars
- **Restructuring charges**: 507,000,000 US dollars
- **Opioid litigation charges**: 0 US dollars
- **Loss on assets held for sale**: 349,000,000 US dollars
- **Store impairments**: 0 US dollars
- **Goodwill impairment**: 0 US dollars
- **Operating expenses**: 39,832,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $8.34 B; to noncontrolling interests: $24.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2023-annual-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2023-annual-revenue-by-business-segment-sankey.png

Income statement for 2023-01-01 through 2023-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 357,776,000,000 US dollars
- **Total operating costs**: 344,033,000,000 US dollars
- **Operating income**: 13,743,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 2,570,000,000 US dollars
- **Income before income tax provision**: 11,173,000,000 US dollars
- **Income tax provision**: 2,805,000,000 US dollars
- **Net income**: 8,368,000,000 US dollars
- **Health Care Benefits**: 105,646,000,000 US dollars
- **Health Services**: 186,843,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 116,763,000,000 US dollars
- **Cost of products sold**: 217,098,000,000 US dollars
- **Health care costs**: 86,247,000,000 US dollars
- **Restructuring charges**: 507,000,000 US dollars
- **Opioid litigation charges**: 0 US dollars
- **Loss on assets held for sale**: 349,000,000 US dollars
- **Store impairments**: 0 US dollars
- **Goodwill impairment**: 0 US dollars
- **Operating expenses**: 39,832,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 409,252,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Intersegment Eliminations**: negative 51,927,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 451,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $8.34 B; to noncontrolling interests: $24.00 M.